Document is current
Any future updates will be listed below
-
Authors
Espinola, Natalia https://orcid.org/0000-0001-5511-3561
Silvestrini, Constanza https://orcid.org/0000-0001-8954-0991
Colaci, Carla https://orcid.org/0000-0002-5397-7531
Sugg, Daniela https://orcid.org/0009-0001-7801-052X
Rojas-Roque, Carlos https://orcid.org/0000-0002-1474-1550
Coelli, Jesica https://orcid.org/0009-0009-1588-3057
Augustovski, Federico https://orcid.org/0000-0002-2914-5022
-
Funding
Funding for this research was provided by:
AstraZeneca Argentina S.A.
- License Information
-
More Information
Article History
Accepted: 23 June 2024
First Online: 13 July 2024
Declarations
:
: This study was made possible by the support of AstraZeneca Argentina S.A. through a research grant. The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.
: Natalia Espinola, Constanza Silvestrini, Carla Colaci, Daniela Sugg, Carlos Rojas-Roque, Jesica Coelli, and Federico Augustovski have no conflicts of interest to declare that are relevant to the contents of this article.
: All data involved in this study are included in the main manuscript and its supplementary information files.
: The model used during the current study is available from the corresponding author upon reasonable request.
: Not applicable.
: Not applicable.
: Not applicable.
: Concept and design: NE. Formal analysis: CS, CC, DS. Review, interpretation and discussion of the results: NE, CS, CC, DS, JC. Writing – original draft: CS, CC. Writing –reviewing and editing, NE, FA, CRR, DS, JC. Approval of the final version of the manuscript, NE, CS, CC, DS, CRR, JC, FA.
